首页> 美国卫生研究院文献>Philosophical Transactions of the Royal Society B: Biological Sciences >The future of organ transplantation: from the laboratory to the clinic.
【2h】

The future of organ transplantation: from the laboratory to the clinic.

机译:器官移植的未来:从实验室到临床。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

This is a short review of tolerance from the point of view of the clinician. Various examples of tolerance occurring in patients and animal models that relate to the clinical experience are described. It is suggested that there may be different mechanisms by which tolerance is achieved, but from the patient's point of view operational tolerance is the goal, whereby, after a short induction procedure, the patient will maintain good function in the grafted organ indefinitely without maintenance immunosuppression. It is pointed out that such a goal may be difficult to achieve with any given protocol due to the enormous variation between donors and recipients of organ grafts of tissue matching, innate immune reactivity and susceptibility to disturbance of a tolerant state by infections or allergic reactions. Thus the case is made for prope or almost tolerance in which graft acceptance is maintained by a low, non-toxic dosage of maintenance immunosuppression that may not be required indefinitely.
机译:从临床医生的角度来看,这是对耐受性的简短回顾。描述了与临床经验有关的患者和动物模型中发生的耐受性的各种实例。提示可能存在不同的机制来实现耐受性,但从患者的角度来看,操作耐受性是目标,即在短暂的诱导过程后,患者将无限期在移植器官中保持良好的功能,而无需维持免疫抑制。应当指出,由于组织匹配的器官移植的供体和受体之间的巨大差异,先天的免疫反应性以及对感染或过敏反应引起的耐受状态的易感性,使用任何给定的方案都可能难以实现这一目标。因此,可以通过适当的低或无毒剂量的维持免疫抑制来维持移植物的接受性,以达到适当的耐受性或几乎是耐受的,这可能是无限期不需要的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号